CorVel Corporation — Form 10-Q Summary
Reporting period: Quarter and nine months ended December 31, 2014, compared with the corresponding 2013 periods. The request metadata says “2013 Q3,” but the filing itself covers the quarter ended December 31, 2014 (CorVel’s fiscal 2015 third quarter).
Business context and results
CorVel provides workers’ compensation and auto medical-cost containment and managed-care services. Its two principal service categories are patient management and network solutions. The company reports one operating segment.
| Metric | Three months ended Dec. 31, 2014 | Change year over year | Nine months ended Dec. 31, 2014 | Change year over year |
|---|---|---|---|---|
| Revenue | $122.4 million | +1.0% | $370.4 million | +3.3% |
| Gross profit | $24.1 million | -12.9% | $77.3 million | -5.7% |
| Gross margin | 19.7% | 22.9% prior year | 20.9% | 22.9% prior year |
| Income before taxes | $10.3 million | -29.0% | $36.5 million | -16.4% |
| Net income | $6.8 million | -22.1% | $23.0 million | -11.7% |
| Diluted EPS | $0.33 | $0.41 prior year | $1.10 | $1.22 prior year |
Cash flow, liquidity and capital
- Cash from operations for the nine months was $33.1 million, down from $45.6 million a year earlier. Management attributed the decline primarily to lower net income and less favorable movements in payables and accrued liabilities.
- Investing used $16.2 million, including $14.8 million for property and equipment and $1.4 million invested in a private-equity partnership. Financing used $20.7 million, primarily for $22.7 million of share repurchases.
- Cash and cash equivalents were $31.0 million at December 31, 2014, versus $34.9 million at March 31, 2014. Working capital was approximately $50.5 million. The company reported no debt outstanding.
- A renewed revolving credit facility provides up to $10 million and expires in September 2015. No loans were outstanding; $4.5 million of letters of credit were issued separately and do not reduce stated borrowing availability.
- CorVel repurchased 584,435 shares for $22.6 million during the nine months. After quarter-end through January 30, 2015, it repurchased another 85,846 shares for $3.0 million.
Material changes and management commentary
- Patient management revenue grew 9.9% in the quarter and 8.8% for the nine-month period, primarily from higher service volumes for TPA customers. Network solutions revenue declined 8.5% in the quarter and 2.6% over nine months, principally because of lower bill-review volumes from wholesale customers.
- The service mix shifted toward lower-margin patient management TPA work and away from higher-margin bill-review services. Cost of revenue rose faster than sales; direct salaries also increased with headcount and raises. These factors drove the decline in gross and pretax margins.
- General and administrative expenses increased 4.8% for the quarter and 6.6% for the nine months, primarily from ongoing investment in proprietary software and IT.
- Effective tax rates were 33.6% for the quarter and 37.0% for nine months, below the respective prior-year rates. Management attributed the decrease to tax-law changes and analysis of state tax filings, and expects the rate to normalize in the next fiscal year.
- Management stated that cash and expected internally generated funds should cover obligations, the current repurchase program, new services and healthcare-related development for at least the next 12 months. No specific earnings or revenue guidance was provided.
Risks, contingencies and unusual items
- Management cited risks including competition, customer losses or insourcing, changes in workers’ compensation claims and regulation, labor costs and staffing, technology investment and execution, system outages or security breaches, and legal or professional-liability exposure.
- The company is involved in ordinary-course litigation; management did not expect the matters to result in material payments. The filing notes that outcomes remain uncertain.
- Unrecognized tax benefits increased from $0.7 million at March 31, 2014 to $2.6 million at December 31, 2014. The contractual-obligations table lists $2.6 million of uncertain tax positions as due within one year.
- The company committed an additional $0.6 million to its private-equity investment within the next 12 months. It reported no impairment of the investment and no indicators of impairment for goodwill or other long-lived assets at quarter-end.
- A new revenue-recognition standard is effective for CorVel’s fiscal year beginning April 1, 2017. The company was evaluating its impact and could not yet estimate it.
Important facts for investors to verify
- Whether patient-management growth can offset continued weakness in network solutions, and whether the mix shift continues to pressure margins.
- Trends in TPA and wholesale-customer volumes, customer retention, and the concentration of growth among new and existing accounts.
- Whether operating cash flow recovers and how capital spending, share repurchases, and the remaining private-equity commitment affect cash balances.
- The resolution and timing of uncertain tax positions, and the expected effective tax rate after management’s stated normalization.
- Availability and renewal terms of the credit facility, which expires in September 2015, and developments in litigation or other contingencies.